Biomedicinos technika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 397,846 | 495,303 | 272,960 | 444,410 | 734,796 | 755,584 | 674,850 | 1,197,636 |
| Profit before tax | 59,550 | 76,260 | 7,396 | 45,751 | 179,951 | 125,720 | 122,200 | 163,423 |
| Net profit | 50,617 | 64,811 | 6,287 | 38,888 | 152,958 | 106,675 | 103,731 | 137,245 |
| Equity | 66,529 | 91,340 | 37,628 | 70,516 | 184,675 | 238,392 | 305,448 | 415,139 |
| Liabilities | 279,813 | 289,232 | 288,933 | 353,205 | 367,691 | 380,251 | 316,100 | 421,548 |
| Non-current assets | 9,090 | 16,518 | 12,696 | 10,077 | 7,112 | 3,843 | 5,147 | 5,418 |
| Current assets | 337,252 | 364,054 | 313,865 | 413,644 | 545,254 | 614,800 | 616,401 | 831,269 |
| Total assets | 346,342 | 380,572 | 326,561 | 423,721 | 552,366 | 618,643 | 621,548 | 836,687 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,948 | 28,273 | 24,706 |
| Social insurance contributions | - | - | - | - | - | 22,410 | 29,720 | 39,195 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +1.3% | +24.5% | -44.9% | +62.8% | +65.3% | +2.8% | -10.7% | +77.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 14.6% | 17.0% | 1.9% | 9.2% | 27.7% | 17.2% | 16.7% | 16.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 76.1% | 71.0% | 16.7% | 55.1% | 82.8% | 44.7% | 34.0% | 33.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 12.7% | 13.1% | 2.3% | 8.8% | 20.8% | 14.1% | 15.4% | 11.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 15.0% | 15.4% | 2.7% | 10.3% | 24.5% | 16.6% | 18.1% | 13.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 4.2 | 3.2 | 7.7 | 5.0 | 2.0 | 1.6 | 1.0 | 1.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 66,308 | 80,319 | 45,493 | 74,068 | 122,466 | 125,931 | 106,556 | 171,091 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biomedicinos technika - Social security debts
The company had no debts to Sodra
Biomedicinos technika - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biomedicinos technika, UAB (code 303170498) is a Private Limited Liability Company engaged in the wholesale of other machinery and equipment. In 2025, the company generated revenue of €1.20M and net profit of €137.2K, with a profit margin of 11.5%. Revenue increased by 77.5% year on year and by 58.5% over two years, showing a strong rebound after the 2024 decline to €674.9K from €755.6K in 2023. Net profit followed a similar pattern, moving from €106.7K in 2023 to €103.7K in 2024 and then to €137.2K in 2025. The balance sheet expanded to €836.7K in assets in 2025, supported mainly by €831.3K in short-term assets, while long-term assets were €5.4K. Equity stood at €415.1K and liabilities at €421.5K, giving an equity ratio of 49.6% and debt-to-equity of 1.02. Profitability remained solid, with ROE at 33.1% and ROA at 16.4%. Asset turnover was 1.43x, and revenue per employee reached €171.1K.